Decentralizing art supply for stable HIV patients to community-based distribution centers: Program outcomes from an urban context in Kinshasa, drc

Journal of Acquired Immune Deficiency Syndromes

Volumn 74, Issue 3, 2017, Pages 326-331

  Vogt, Florian ^a   Kalenga, Lucien ^b   Lukela, Jean ^c   Salumu, Freddy ^d   Diallo, Ibrahim ^b   Nico, Elena ^b   Lampart, Emmanuel ^b   Van Den Bergh, Rafael ^e   Shah, Safieh ^e   Ogundahunsi, Olumide ^f   Zachariah, Rony ^e   Van Griensven, Johan ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c Réseau National des Organisations d'Assise Communautaires   (Congo)

^d Ministry of Health   (Congo)

^e MÉDECINS SANS FRONTIÈRES   (Belgium)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Antiretroviral therapy; Community; Decentralization; HIV; Task shifting; Urban

Indexed keywords

EFAVIRENZ; NEVIRAPINE; STAVUDINE; ANTIRETROVIRUS AGENT;

ADULT; ANTIRETROVIRAL THERAPY; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CONGO; CONGOLESE (KINSHASA); DECENTRALIZATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; URBAN POPULATION; ADOLESCENT; COHORT ANALYSIS; DEMOCRATIC REPUBLIC CONGO; HEALTH CARE DELIVERY; HIV INFECTIONS; MIDDLE AGED; SUPPLY AND DISTRIBUTION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; DELIVERY OF HEALTH CARE; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; URBAN POPULATION; YOUNG ADULT;

EID: 84992692450     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000001215     Document Type: Article

References (50)

1. Joint United Nations Programme on HIV/AIDS. How AIDS Changed Everything. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2015.
2. Price J, Binagwaho A. From medical rationing to rationalizing the use of human resources for AIDS care and treatment in Africa: a case for task shifting. Dev World Bioeth. 2010;10:99-103.
3. Young T, Busgeeth K. Home-based care for reducing morbidity and mortality in people infected with HIV/AIDS. Cochrane database Syst Rev. 2010:CD005417.
4. Decroo T, Rasschaert F, Telfer B, et al. Community-based antiretroviral therapy programs can overcome barriers to retention of patients and decongest health services in sub-Saharan Africa: a systematic review. Int Health. 2013;5:169-179.
5. Mwai GW, Mburu G, Torpey K, et al. Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2013;16:18586.
6. Wouters E, Van Damme W, van Rensburg D, et al. Impact of community-based support services on antiretroviral treatment programme delivery and outcomes in resource-limited countries: a synthetic review. BMC Health Serv Res. 2012;12:194.
7. Demographia. Demographia World Urban Areas. 11th Annual ed. 2015. Available at: http://www.demographia.com/db-worldua.pdf. Accessed November 10, 2016.
8. Ministère du Plan et Suivi de la Mise en oeuvre de la Révolution de la Modernité, Ministère de la Santé Publique, ICF International. Enquête Démographique et de Santé en République Démocratique du Congo 2013-2014. Rockville, MD: ICF International; 2014.
9. Joint United Nations Programme on HIV/AIDS. The Gap Report. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2014.
10. L'Union Congolaise des Organisations des Personnes vivant avec le VIH. Index de stigmatisation et de discrimination des personnes vinant avec le VIH en RDC. Kinshasa, Democratic Republic of the Congo: L'Union Congolaise des Organisations des Personnes vivant avec le VIH; 2012.
11. World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach-2010 Revision. Geneva, Switzerland: World Health Organization; 2010.
12. Cohen R, Lynch S, Bygrave H, et al. Antiretroviral treatment outcomes from a nurse-driven, community-supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years. J Int AIDS Soc. 2009;12:23.
13. Abaasa AM, Todd J, Ekoru K, et al. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of the AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv Res. 2008;8:241.
14. Bedelu M, Ford N, Hilderbrand K, et al. Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/ AIDS care. J Infect Dis. 2007;196:S464-S468.
15. Nachega JB, Chaisson RE, Goliath R, et al. Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy. AIDS. 2010;24:1273-1280.
16. Igumbor JO, Scheepers E, Ebrahim R, et al. An evaluation of the impact of a community-based adherence support programme on ART outcomes in selected government HIV treatment sites in South Africa. AIDS Care. 2011;23:231-236.
17. Rich ML, Miller AC, Niyigena P, et al. Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda. J Acquir Immune Defic Syndr. 2012;59:e35-e42.
18. Zachariah R, Teck R, Buhendwa L, et al. Community support is associated with better antiretroviral treatment outcomes in a resourcelimited rural district in Malawi. Trans R Soc Trop Med Hyg. 2007;101: 79-84.
19. Chang LW, Kagaayi J, Nakigozi G, et al. Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial. PLoS One. 2010;5:e10923.
20. Torpey KE, Kabaso ME, Mutale LN, et al. Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia. PLoS One. 2008;3: e2204.
21. Jaffar S, Amuron B, Foster S, et al. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet. 2009; 374:2080-2089.
22. Amuron B, Levin J, Birunghi J, et al. Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study. AIDS Res Ther. 2011;8:39.
23. Wools-Kaloustian KK, Sidle JE, Selke HM, et al. A model for extending antiretroviral care beyond the rural health centre. J Int AIDS Soc. 2009; 12:22.
24. Selke HM, Kimaiyo S, Sidle JE, et al. Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya. J Acquir Immune Defic Syndr. 2010;55:483-490.
25. Kipp W, Konde-Lule J, Saunders LD, et al. Results of a communitybased antiretroviral treatment program for HIV-1 infection in Western Uganda. Curr HIV Res. 2010;8:179-185.
26. Kipp W, Konde-Lule J, Saunders LD, et al. Antiretroviral treatment for HIV in rural Uganda: two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort. PLoS One. 2012;7:e40902.
27. Weidle PJ, Wamai N, Solberg P, et al. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet. 2006;368:1587-1594.
28. Mermin J, Were W, Ekwaru JP, et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIVuninfected children: a prospective cohort study. Lancet. 2008;371:752-759.
29. Moore DM, Yiannoutsos CT, Musick BS, et al. Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2011;58:289-296.
30. Decroo T, Telfer B, Biot M, et al. Distribution of antiretroviral treatment through self-forming groups of patients in Tete Province, Mozambique. J Acquir Immune Defic Syndr. 2011;56:e39-e44.
31. Decroo T, Koole O, Remartinez D, et al. Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique. Trop Med Int Health. 2014;19:514-521.
32. Vandendyck M, Motsamai M, Mubanga M. Community-based ART resulted in excellent retention and can leverage community empowerment in rural Lesotho, a mixed method study. HIV/AIDS Res Treat. 2015;2:44-50.
33. Luque-Fernandez MA, Van Cutsem G, Goemaere E, et al. Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One. 2013;8:e56088.
34. Callaghan M, Ford N, Schneider H. A systematic review of task-shifting for HIV treatment and care in Africa. Hum Resour Health. 2010;8:8.
35. Fox MP, Rosen S. Retention of adult patients on antiretroviral therapy in low-and middle-income countries: systematic review and meta-analysis 2008-2013. J Acquir Immune Defic Syndr. 2015;69:98-108.
36. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056.
37. Joint United Nations Programme on HIV/AIDS, Médecins Sans Frontières. Community-based Antiretroviral Therapy Delivery. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2015.
38. Koole O, Kalenga L, Kiumbu M, et al. Retention in a NGO supported antiretroviral program in the Democratic Republic of Congo. PLoS One. 2012;7:e40971.
39. Tassie JM, Baijal P, Vitoria MA, et al. Trends in retention on antiretroviral therapy in national programs in low-income and middleincome countries. J Acquir Immune Defic Syndr. 2010;54:437-441.
40. World Health Organization. Towards Universal Access-Scaling up Priority HIV/AIDS Interventions in the Health Sector. Geneva, Switzerland: World Health Organization; 2009.
41. Van Griensven J, Zachariah R, Rasschaert F, et al. Stavudine-and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda. Trans R Soc Trop Med Hyg. 2010;104:148-153.
42. Subbaraman R, Chaguturu SK, Mayer KH, et al. Adverse effects of highly active antiretroviral therapy in developing countries. Clin Infect Dis. 2007;45:1093-1101.
43. Mdege ND, Chindove S, Ali S. The effectiveness and cost implications of task-shifting in the delivery of antiretroviral therapy to HIV-infected patients: a systematic review. Health Policy Plan. 2013;28:223-236.
44. Lazarus JV, Safreed-Harmon K, Nicholson J, et al. Health service delivery models for the provision of antiretroviral therapy in sub-Saharan Africa: a systematic review. Trop Med Int Health. 2014;19:1198-1215.
45. Wringe A, Cataldo F, Stevenson N, et al. Delivering comprehensive home-based care programmes for HIV: a review of lessons learned and challenges ahead in the era of antiretroviral therapy. Health Policy Plan. 2010;25:352-362.
46. Rabkin M, El-Sadr WM, De Cock KM. The impact of HIV scale-up on health systems: a priority research agenda. J Acquir Immune Defic Syndr. 2009;52(suppl 1):S6-S11.
47. World Health Organization. March 2014 Supplement to the 2013 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Geneva, Switzerland: World Health Organization; 2014.
48. Programme National Multisectoriel de Lutte contre le Sida République Démocratique du Congo. Plan Stratégique National de lutte contre le VIH et le sida 2014-2017. Kinshasa, Democratic Republic of the Congo: Programme National Multisectoriel de Lutte contre le Sida République Démocratique du Congo; 2014.
49. Yu JK, Chen SC, Wang KY, et al. True outcomes for patients on antiretroviral therapy who are lost to follow-up in Malawi. Bull World Health Organ. 2007;85:550-554.
50. Bisson GP, Gaolathe T, Gross R, et al. Overestimates of survival after HAART: implications for global scale-up efforts. PLoS One. 2008;3:e1725.